Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to ritlecitinib with or without narrow-band UVB add-on therapy in patients with active nonsegmental vitiligo: results from a phase 2b extension study.
Yamaguchi Y, Peeva E, Adiri R, Ghosh P, Napatalung L, Hamzavi I, Pandya AG, Shore RN, Ezzedine K, Guttman-Yassky E. Yamaguchi Y, et al. Among authors: hamzavi i. J Am Acad Dermatol. 2024 Dec 19:S0190-9622(24)03381-4. doi: 10.1016/j.jaad.2024.11.064. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39709084
Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years.
Harris JE, Pandya AG, Lebwohl M, Hamzavi IH, Grimes P, Gottlieb AB, Sofen HL, Moore AY, Wang M, Kornacki D, Butler K, Rosmarin D. Harris JE, et al. Among authors: hamzavi ih. Skin Health Dis. 2024 Aug 7;4(6):e404. doi: 10.1002/ski2.404. eCollection 2024 Dec. Skin Health Dis. 2024. PMID: 39624731 Free PMC article. No abstract available.
A Canvas of Contemporary Insights into Clinical Vitiligo.
Mokhtari M, Bardhi R, Hamzavi I. Mokhtari M, et al. Among authors: hamzavi i. Dermatol Clin. 2025 Jan;43(1):67-76. doi: 10.1016/j.det.2024.08.005. Epub 2024 Oct 20. Dermatol Clin. 2025. PMID: 39542565 Review.
A diverse hidradenitis suppurativa cohort: A retrospective cross-sectional study of 13,130 patients from a large US health care system database from 1995 to 2022.
Young KZ, Loveless I, Su WK, Veenstra J, Yin C, Dimitrion P, Krevh R, Zhou L, She R, Pan M, Levin AM, Young A, Samir E, Dai A, Ge J, Huggins RH, de Guzman Strong C, Lim HW, Ozog DM, Hamzavi I, Adrianto I, Mi QS. Young KZ, et al. Among authors: hamzavi i. J Am Acad Dermatol. 2024 Nov 10:S0190-9622(24)03121-9. doi: 10.1016/j.jaad.2024.10.073. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39532232
Cellular indexing of transcriptomes and epitopes (CITE-Seq) in hidradenitis suppurativa identifies dysregulated cell types in peripheral blood and facilitates diagnosis via machine learning.
Kumar S, Orcales F, Shih BB, Fang X, Yin C, Yates A, Dimitrion P, Neuhaus I, Johnson C, Adrianto I, Wiala A, Hamzavi I, Zhou L, Naik H, Posch C, Mi QS, Liao W. Kumar S, et al. Among authors: hamzavi i. Res Sq [Preprint]. 2024 Sep 9:rs.3.rs-4791069. doi: 10.21203/rs.3.rs-4791069/v1. Res Sq. 2024. PMID: 39315268 Free PMC article. Preprint.
Challenges of tinted sunscreen in skin of color.
Xue GR, Hamzavi IH, Kohli I, Mohammad TF. Xue GR, et al. Among authors: hamzavi ih. Int J Dermatol. 2024 Sep;63(9):e221-e222. doi: 10.1111/ijd.17347. Epub 2024 Jun 21. Int J Dermatol. 2024. PMID: 39215428 No abstract available.
Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation.
Hamzavi IH, Ganesan AK, Mahmoud BH, Weiss E, Ahmed AM, Robinson D, Goldman MP, Munavalli G, Kahn SA, Huang V, Waibel J, Desai A, Elbuluk N, Desai S, Pandya AG. Hamzavi IH, et al. J Am Acad Dermatol. 2024 Dec;91(6):1104-1112. doi: 10.1016/j.jaad.2024.08.027. Epub 2024 Sep 7. J Am Acad Dermatol. 2024. PMID: 39182674 Free article. Clinical Trial.
284 results